Drug intelligence / Profile preview

Huoxue Tongluo Decoction

Development stage: Unknown
Lead developer: Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
Administration: Oral

Overview

Huoxue Tongluo Decoction (HXTLD) is a traditional Chinese medicine (TCM) prescription, specifically an andrology prescription developed by the Dongzhimen Hospital of Beijing University of Chinese Medicine. It has been widely used clinically for many years, particularly for the treatment of complex erectile dysfunction (ED). Traditionally, its functions include activating blood to alleviate blood stasis, dredging collaterals, invigorating the kidneys, and warming yang.

Other names: 活血通络汤

Targets

VEGFA (Vascular endothelial growth factor A)NOS3 (eNOS)

Beyond the preview

Go deeper on Huoxue Tongluo Decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Huoxue Tongluo Decoction.

Explore the full profile